Type I Interferonopathies in Inborn Errors of Immunity: Pathogenesis, Clinical phenotype, Diagnosis and Management
Scandinavian Journal of Immunology · 2026-11 · 104 (5)
DOI: 10.1111/sji.70162 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Scandinavian Journal of Immunology, online erschienen am 10.11.2026. Verfasst von Fatemeh Zeinali und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of medicine, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Interferon Type I. Die Arbeit nennt 99 Literaturangaben.
Abstract (Originalsprache)
Type I interferonopathies represent a heterogeneous group of inborn errors of immunity (IEI), characterized by dysregulated and persistent activation of the Type I interferon pathway. These patients present a broad spectrum of clinical phenotypes involving the nervous system, skin, lungs, and haematopoietic system. Diagnosis is often challenging owing to overlap with other autoinflammatory and autoimmune conditions. In parallel with the expanding molecular spectrum of these disorders, their classification within IEI has continued to evolve. This review provides an updated synthesis of Type I interferonopathies in the context of the 2024 International Union of Immunological Societies (IUIS) classification, linking the underlying genetic defects and dysregulated interferon pathways to their characteristic and overlapping clinical phenotypes. Particular emphasis is placed on a practical diagnostic framework integrating clinical recognition, interferon‐based biomarkers, and molecular testing, as well as on the transition from conventional immunomodulation toward pathway‐directed therapies, including the growing clinical experience with Janus kinase inhibitors. This review integrates current knowledge on the pathogenesis, clinical features, diagnostic approaches, and treatment strategies in patients with Type I interferonopathies, providing an updated clinically oriented framework for their recognition, diagnosis, and management within the expanding spectrum of IEIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of medicine, Iran University of Medical Sciences, Tehran, Iran.
- Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
- Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
ORCID-Profile: Nima Rezaei, Reza Yazdani
Zitieren
APA
Zeinali, F., Rezaei, N., & Yazdani, R. (2026). Type I Interferonopathies in Inborn Errors of Immunity: Pathogenesis, Clinical phenotype, Diagnosis and Management. Scandinavian Journal of Immunology, 104(5). https://doi.org/10.1111/sji.70162
Vancouver
Zeinali F, Rezaei N, Yazdani R. Type I Interferonopathies in Inborn Errors of Immunity: Pathogenesis, Clinical phenotype, Diagnosis and Management. Scandinavian Journal of Immunology. 2026;104(5). doi:10.1111/sji.70162
BibTeX
@article{Zeinali2026,
author = {Zeinali, Fatemeh and Rezaei, Nima and Yazdani, Reza},
title = {Type I Interferonopathies in Inborn Errors of Immunity: Pathogenesis, Clinical phenotype, Diagnosis and Management},
journal = {Scandinavian Journal of Immunology},
year = {2026},
volume = {104},
number = {5},
doi = {10.1111/sji.70162}
}
EUVIMED